The anticancer effects of sericin were found to be due to a reduction in Bcl-2, which is a regulatory factor that promotes or inhibits apoptosis, and increased activity of caspase-3, which is an active factor in the end process of apoptosis that stimulates the apoptosis of colon cancer cells [94]. The gene discussed is BCL2; the disease is colonic neoplasm.